|
Volumn 23, Issue 1, 2003, Pages 151-158
|
Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
DNA FRAGMENT;
HRAS PROTEIN, HUMAN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEVALONIC ACID;
MEVINOLIN;
PROTEIN P21;
SERINE;
THREONINE;
TYROSINE;
APOPTOSIS;
ARTICLE;
BIOSYNTHESIS;
CELL CYCLE;
CELL DIVISION;
CELL STRAIN K 562;
CHEMISTRY;
CHRONIC MYELOID LEUKEMIA;
DOSE RESPONSE;
FLOW CYTOMETRY;
HUMAN;
METABOLISM;
PHOSPHORYLATION;
PROTEIN PROCESSING;
TIME;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL CYCLE;
CELL DIVISION;
CELL LINE, TUMOR;
DNA FRAGMENTATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FLOW CYTOMETRY;
FUSION PROTEINS, BCR-ABL;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INTERFERON ALFA-2B;
K562 CELLS;
LEUKEMIA, MYELOID, CHRONIC;
LOVASTATIN;
MEVALONIC ACID;
PHOSPHORYLATION;
PROTEIN ISOPRENYLATION;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
PROTO-ONCOGENE PROTEINS P21(RAS);
SERINE;
THREONINE;
TIME FACTORS;
TYROSINE;
|
EID: 1542540830
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (0)
|